Literature DB >> 14600512

Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world.

Evan Wood, Julio S G Montaner, David R Bangsberg, Mark W Tyndall, Steffanie A Strathdee, Michael V O'Shaughnessy, Robert S Hogg.   

Abstract

Mesh：

Year:  2003        PMID： 14600512     DOI： 10.1097/00002030-200311210-00003

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  26 in total

1.  The HIV Epidemic Among Individuals with Mental Illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr Infect Dis Rep       Date:  2004-10       Impact factor: 3.725

2.  No evidence of increased sexual risk behaviour after initiating antiretroviral therapy among people who inject drugs.

Authors:  Brandon D L Marshall; M-J Milloy; Thomas Kerr; Ruth Zhang; Julio S G Montaner; Evan Wood
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

3.  Reason and rights in global drug control policy.

Authors:  Richard Elliott; Joanne Csete; Anita Palepu; Thomas Kerr
Journal:  CMAJ       Date:  2005-03-01       Impact factor: 8.262

Review 4.  The population effectiveness of highly active antiretroviral therapy: are good drugs good enough?

Authors:  Thomas P Giordano; Maria E Suarez-Almazor; Richard M Grimes
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

5.  Assessment of HIV testing of urban injection drug users: implications for expansion of HIV testing and prevention efforts.

Authors:  Robert Heimer; Lauretta E Grau; Erin Curtin; Kaveh Khoshnood; Merrill Singer
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

Review 6.  The HIV epidemic among individuals with mental illness in the United States.

Authors:  Sheri D Weiser; William R Wolfe; David R Bangsberg
Journal:  Curr HIV/AIDS Rep       Date:  2004-12       Impact factor: 5.071

7.  A closer look at depression and its relationship to HIV antiretroviral adherence.

Authors:  Glenn J Wagner; Kathy Goggin; Robert H Remien; Marc I Rosen; Jane Simoni; David R Bangsberg; Honghu Liu
Journal:  Ann Behav Med       Date:  2011-12

8.  Factors associated with utilization of HAART amongst hard-to-reach HIV-infected individuals in Atlanta, Georgia.

Authors:  Paulina Rebolledo; Ekaterina Kourbatova; Richard Rothenberg; Carlos Del Rio
Journal:  J AIDS HIV Res       Date:  2011-03

9.  Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trials.

Authors:  Marya Viorst Gwadz; Pablo Colon; Amanda S Ritchie; Noelle R Leonard; Charles M Cleland; Marion Riedel; DeShannon Bowens; Angela D Banfield; Patricia Chang; Robert Quiles; Donna Mildvan
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

10.  Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.

Authors:  Elena Losina; Bruce R Schackman; Sara N Sadownik; Kelly A Gebo; Rochelle P Walensky; John J Chiosi; Milton C Weinstein; Perrin L Hicks; Wendy H Aaronson; Richard D Moore; A David Paltiel; Kenneth A Freedberg
Journal:  Clin Infect Dis       Date:  2009-11-15       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.